Doxorubicin-Ioaded Fe3O4@MoS2-PEG-2DG nanocubes as a theranostic platform for magnetic resonance imaging- guided chemo-photothermal therapy of breast cancer
Doxorubicin-Ioaded Fe3O4@MoS2-PEG-2DG nanocubes as a theranostic platform for magnetic resonance imaging- guided chemo-photothermal therapy of breast cancer作者机构:State Key Laboratory of New Ceramics and Fine Processing School of Materials Science & Engineering Tsinghua University Beijing 100084 China Key Laboratory of Advanced Materials Ministry of Education of China School of Materials Science & Engineering Tsinghua University Beijing 100084 China School of Chemical and Biomolecular Engineering Notional University of Singapore 119077 Singapore College of Chemistry and Materials Science Northwest University Xi'an 710069 China
出 版 物:《Nano Research》 (纳米研究(英文版))
年 卷 期:2018年第11卷第5期
页 面:2470-2487页
核心收录:
学科分类:0832[工学-食品科学与工程(可授工学、农学学位)] 082403[工学-水声工程] 08[工学] 0824[工学-船舶与海洋工程] 083203[工学-农产品加工及贮藏工程]
基 金:This study was supported by the National Natural Science Foundation of China (NSFC) (No. 81671829)
主 题:iron oxide nanocubes molybdenum disulfide multimodality therapy photothermal therapy nanotheranostics
摘 要:Molybdenum disulfide (MoS2), a typical transition-metal dichalcogenide, has attracted increasing attention in the field of nanomedicine because of its preeminent properties. In this study, magnetic resonance imaging (MRI)-guided chemo-photothermal therapy of human breast cancer xenograft in nude mice was demonstrated using a novel core/shell structure of Fe3O4@MoS2 nanocubes (IOMS NCs) via the integration of MoS2 (MS) film onto iron oxide (IO) nanocubes through a facile hydrothermal method. After the necessary PEGylation modification of the NCs for long-circulation purposes, such PEGylated NCs were further capped by 2-deoxy-D-glucose (2-DG), a non-metabolizable glucose analogue to increase the accumulation of the as-prepared NCs at the tumor site, as 2-DG molecules could be particularly attractive to resource-hungry cancer cells. Such 2-DG- modified PEGylated NCs (IOMS-PEG-2DG NCs) acted as drug-carriers for doxorubicin (DOX), which could be easily loaded within the NCs. The obtained IOMS-PEG(DOX)-2DG NCs exhibited a 3?2 relaxivity coefficient of 48.86 (mM)^-1·s^-1 and excellent photothermal performance. 24 h after intravenous injection of IOMS-PEG(DOX)-2DG NCs, the tumor site was clearly detected by enhanced T2-weighted MRI signal. Upon exposure to an NIR 808-nm laser for 5 rain at a low power density of 0.5 W·cm^-2 a marked temperature increase was noticed within the tumor site, and the tumor growth was efficiently inhibited by the chemo-photothermal effect. Therefore, our study highlights an excellent theranostic platform with great potential for targeted MRI-guided precise chemo-photothermal therapy of breast cancer.